NABA ALSAHA
9546NomuHealth Care Equipment & Svc
- Open
- 21.00
- High
- 22.00
- Low
- 21.00
- Prev. close
- 22.00
- Volume
- 10.29K
- Value
- 0.23M
- Trades
- 13
9546NomuHealth Care Equipment & Svc
Coming soon
We are confirming a reliable source for this data and its terms of use before adding it.
Coming soon
We are confirming a reliable source for this data and its terms of use before adding it.
No private deals recorded for this company.
Naba Al Saha Medical Services Company operates private and governmental hospitals, and health facilities in the Kingdom of Saudi Arabia. It owns, operates, and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and Nab'a Al-Sahah branch. The company provides outpatient, inpatient, clinics, and operation services; emergency and intensive care services; maintenance of electromechanical systems; maintenance and cleaning services; and building operation services. It is involved in construction and maintenance of medical facilities; provision of strategic consulting; training of medical and administrative personnel; development of therapeutic programs and medical services; quality management; and pharmacy operation, as well as operates hospital. The company was founded in 1984 and is based in Al Khobar, the Kingdom of Saudi Arabia.
14 September 2026Partnership & contractsImportant
شركة نبع الصحة للخدمات الطبية تعلن الموافقة على أوامر تغييرية للأعمال الكهربائية مع شركة الكيان الفنية العربية للمقاولات، بزيادة تكلفة المشروع إلى 121,275,360.53 ريال وتمديد مدة التنفيذ حتى 31 يناير 2027.
26 August 2026Financial results
شركة نبع الصحة للخدمات الطبية تعلن عن أرباح نصف السنة الأولى 2026 بارتفاع 7% لتصل إلى 15.2 مليون ريال، مع نمو الإيرادات وتحسن الكفاءة التشغيلية.
9 August 2026ExpansionImportant
شركة نبع الصحة للخدمات الطبية تعلن عن شراء أرض بمساحة 27,533.52 متر مربع في حي دانة الرامس بمدينة القطيف بقيمة 48.4 مليون ريال لإنشاء مركز صحي جديد، ضمن خطط التوسع وفتح فروع جديدة.
17 June 2026Regulatory actionImportant
تداول السعودية تعلن إنهاء اتفاقية صناعة السوق لشركة نبع الصحة للخدمات الطبية اعتباراً من 17 يونيو 2026.
52-week range
| Eligibility | Distribution | Amount |
|---|---|---|
| 23 Mar 2025 | 10 Apr 2025 | 0.30 |
| 22 Jun 2023 | 10 Jul 2023 | 0.30 |
| Company | Price | Change % | Market cap | P/E | Net margin | Dividend yield |
|---|---|---|---|---|---|---|
| SULAIMAN ALHABIB 4013 | 227.60 | (0.48%) | 79.66B | 32.9 | 17.52% | 2.14% |
| MOUWASAT 4002 | 61.55 | (0.73%) | 12.31B | 14.5 | 25.51% | 3.45% |
| DALLAH HEALTH 4004 | 78.35 | 1.62% | 9.55B | 18.6 | 13.24% | 2.55% |
| FAKEEH CARE 4017 | 34.42 | 0.41% | 7.99B | 41.0 | 9.39% | 0.96% |
| CHEMICAL 2230 | 7.17 | (0.69%) | 6.05B | 17.1 | 4.87% | 1.39% |
| ALMOOSA 4018 | 115.60 | (0.86%) | 5.12B | 26.2 | 16.70% | 1.04% |
| 107.00 | (1.74%) | 4.80B | 16.0 | 19.90% | 2.80% | |
| 22.63 | 0.09% | 3.62B | 15.0 | 19.59% | 3.84% | |
| 14.45 | (2.63%) | 3.61B | 13.0 | 17.30% | 7.75% | |
| 27.28 | (1.37%) | 2.51B | 17.3 | 9.73% | 1.83% |